MedTrace Logo

Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.

NCT00142246 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 6758

Last updated 2017-01-26

No results posted yet for this study

Summary

This study seeks to establish whether intermittent preventive treatment (IPT) can reduce malaria among school-going children and its consequent impact on school performance.

Conditions

  • Malaria, Falciparum

Interventions

DRUG

Intermittent preventive treatment (SP and amodiaquine)

Oral medication. SP: single dose given over one day; amodiaquine: 3 daily doses over 3 days. Dosage has given according to age.

OTHER

Placebo

Three doses given over three days (Day 1: placebo SP + placebo AQ; Days 2 and 3: placebo AQ). Dosage given according to age

Sponsors & Collaborators

  • University of Nairobi

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Sian E Clarke, PhD · London School of Hygiene and Tropical Medicine, University of London, UK

  • Simon J Brooker, PhD · London School of Hygiene and Tropical Medicine, University of London, UK

  • Benson BA Estambale, MBChB, PhD · University of Nairobi

  • Matthew CH Jukes, PhD · Partnership for Child Development, Imperial College, University of London, UK

  • Pascal Magnussen, MD · DBL - Institute for Health Research and Development, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00142246 on ClinicalTrials.gov